Table 3

Laboratory data and medical interventions by treatment group

Laboratory dataRinger’s lactate initialRinger’s lactate finalNormal saline initialNormal saline finalTotal initialTotal final
Bicarbonate, mmol/L
(mean±SD)
13.7±5.522.1±3.816.4±6.620.0±4.015.1±6.021.0±4.0
Anion gap, mmol/L
(mean±SD)
27.8±9.811.9±2.723.6±7.613.0±3.825.5±8.912.5±3.3
Serum lactate, mmol/L (median (IQR))1.9 (1.3–4.7)1.4 (0.8–2.3)2.8 (1.8–4.9)3.2 (2.4–3.6)2.8 (1.7–4.9)2.1 (1.0–3.0)
Creatinine, µmol/L (median (IQR))82.0 (59.0–270.0)84.0 (50.0–246.0)95.0 (75.0–159.0)76.0 (63.0–133.0)81.5 (64.0–158.3)76.0 (51.5–141.0)
β-hydroxybutyrate, mmol/L (median (IQR))5.75 (4.14–8.95)0.69 (0.66–0.73)4.07 (2.08–6.96)0.12 (0.11–0.12)4.45 (2.40–8.58)0.38 (0.12–0.66)
Blood gas: pH
(mean±SD)
7.22±0.127.35±0.067.24±0.177.34±0.067.23±0.147.35±0.06
Blood gas: pCO2
(mean±SD)
35.0±8.639.6±6.734.7±11.639.4±6.334.9±10.039.5±6.4
Blood gas: pO2
(mean±SD)
39.1±15.247.3±19.241.9±15.247.4±19.640.4±15.047.3±19.2
Blood gas: bicarbonate (mean±SD)17.2±6.824.0±5.417.6±7.621.8±5.617.9±7.023.0±5.5
Blood gas: lactate (median (IQR))2.3 (1.7–3.9)1.8 (1.2–2.2)2.1 (1.6–3.2)1.3 (1.1–2.5)2.2 (1.6–3.5)1.4 (1.1–2.3)
Serum glucose, mmol/L (mean±SD)29.0±12.011.5±4.026.5±9.910.1±5.227.7±10.910.8±4.7
Medical interventionRinger’s lactate (n=25)Normal saline (n=27)Total (n=52)
Prestudy fluid administered, n (%)4 (16.0)3 (11.1)7 (13.5)
Insulin infusion administered, n (%)23 (92.0)23 (85.2)46 (88.5)
Duration of insulin infusion (hours, median (IQR))15.9 (5.7–39.2)15.5 (6.7–36.4)15.7 (6.7–38.2)
Sodium bicarbonate administered, n (%)4 (16.0)1 (3.7)5 (9.6)
Sodium chloride 0.45% administered, n (%)11 (44.0)6 (22.2)17 (32.7)
Total amount of study fluid administered, mL (mean±SD)1568.0±644.71388.9±847.31475.0±754.8
  • SD (not included if n≤1).

  • pCO2, partial pressure of carbon dioxide; pO2, partial pressure of oxygen.